Company:  INCYTE CORP (INCY)
Form Type:  10-Q
Filing Date:  7/30/2019 
CIK:  0000879169 
Address:  1801 AUGUSTINE CUT-OFF 
City, State, Zip:  WILMINGTON, Delaware 19803 
Telephone:  (302) 498-6700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$81.21  
Change: 
3.09 (3.96%)  
Trade Time: 
Sep 20  
Market Cap: 
$17.47B
Trade INCY now with 

© 2019  
Description of Business
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. Our global headquarters is located in Wilmington, Delaware. We conduct our European clinical development operations from our offices in Geneva, Switzerland, and Lausanne, Switzerland; our Japanese office is in Tokyo.
Register and access this filing in:     
  FORM 10-Q
    PART I: FINANCIAL INFORMATION
      Item 1. Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II: OTHER INFORMATION
      Item 1A. Risk Factors
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
  EXHIBIT 32.2